RanLOS AB Series B (RLOS-B) - Total Liabilities
Based on the latest financial reports, RanLOS AB Series B (RLOS-B) has total liabilities worth Skr4.90 Million SEK (≈ $527.53K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See RLOS-B working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
RanLOS AB Series B - Total Liabilities Trend (2022–2025)
This chart illustrates how RanLOS AB Series B's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of RanLOS AB Series B.
RanLOS AB Series B Competitors by Total Liabilities
The table below lists competitors of RanLOS AB Series B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BIO-Key International Inc
NASDAQ:BKYI
|
USA | $3.20 Million |
|
iTonic Holdings Ltd.
NASDAQ:ITOC
|
USA | $969.83K |
|
Mercator Limited
NSE:MERCATOR
|
India | Rs24.65 Billion |
|
Pensana Rare Earths Plc
LSE:PRE
|
UK | GBX20.79 Million |
|
Imagion Biosystems Ltd
AU:IBX
|
Australia | AU$4.21 Million |
|
Atlantic Sapphire As
OL:ASA
|
Norway | Nkr123.89 Million |
|
Andrews Sykes Group plc
LSE:ASY
|
UK | GBX33.85 Million |
|
Prestal Holdings Ltd
AU:PTL
|
Australia | AU$4.34 Million |
Liability Composition Analysis (2022–2025)
This chart breaks down RanLOS AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of RanLOS AB Series B to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.10 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.30 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how RanLOS AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for RanLOS AB Series B (2022–2025)
The table below shows the annual total liabilities of RanLOS AB Series B from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr4.90 Million ≈ $527.53K |
-11.76% |
| 2024-12-31 | Skr5.55 Million ≈ $597.81K |
+181.41% |
| 2023-12-31 | Skr1.97 Million ≈ $212.43K |
-44.08% |
| 2022-12-31 | Skr3.53 Million ≈ $379.88K |
-- |
About RanLOS AB Series B
RanLOS AB (publ) provides test systems for vehicles, base stations, antennas, and other connected devices in Sweden. It offers RanLOS Sub-6 GHz test system for measuring devices, including vehicles and base stations; and RanLOS mmWave test system for measuring devices, such as mobile phones and base stations at higher frequencies. The company also provides RanLOS measurement software that control… Read more